Inhibitors of cyclin dependent kinases as anti-cancer agent
US7262202B2 · kind B2 · utility
4Cited by
0References
41Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 24, 2003 |
| Grant date | Aug 28, 2007 |
| Priority date | — |
| Expiry date | Sep 24, 2023 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to 2-substituted 4-heteroaryl-pyrimidines, their preparation, pharmaceutical compositions containing them and their use as inhibitors of cyclin-dependent kinases (CDKs) and hence their use in the treatment of proliferative disorders such as cancer, leukaemia, psoriasis and the like.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.